| Model Number |
BA28-70/I16-30 |
| Medical Device Problem Codes |
Loss of or Failure to Bond (1068); Leak/Splash (1354); Material Puncture/Hole (1504)
|
| Health Effect - Clinical Code |
Failure of Implant (1924)
|
| Date of Event |
10/04/2018
|
|
Type of Reportable Event
|
Serious Injury
|
|
Additional Manufacturer Narrative
|
|
The devices involved in the event will not be returned for evaluation, they remain implanted in the patient.If additional information pertinent to the incident is obtained, a follow-up report will be submitted.
|
| |
|
Event or Problem Description
|
|
The patient was initially implanted with an afx device to treat an aneurysm.Recently the patent was presented with strata and a type 3 endoleak (indeterminate origin).As of the date of this report there have been no additional patient sequelae reported and secondary planned procedure is unknown.The patient status as unknown and no additional information was provided.
|
| |
|
Additional Manufacturer Narrative
|
|
A clinical evaluation of the reported event could not be completed due to a lack of receipt of relevant medical records and/or imaging.Requests were made and no response was received.As such, event determination, off label conditions, related patient harms and patient disposition could not be independently assessed.The manufacturing lot review confirmed all devices met specifications prior to release.Endologix continues to investigate this event and similar events to ensure the highest quality and patient safety.A root cause investigation was carried out for all afx complaints having an identified failure mode of a type iiib endoleak.Endologix implemented the following corrective actions with the intent of reducing type iiib endoleak events; upgraded graft material (i.E.Duraply) and updates to the ifu and additional physician training.The change to duraply graft material and the ifu changes were put in place july 2014.
|
| |
|
Search Alerts/Recalls
|